Top-News
Professionelle Dienstleistungen Schweiz

Relief Therapeutics SA Aktie

Aktie
WKN:  A3EFB5 ISIN:  CH1251125998 US-Symbol:  RLFTF
5,9295 €
-0,8221 €
-12,18%
6,45 $ 31.10.24
Handeln Depot/Watchlist
Aktienanzahl *
11,01 Mio.
Marktkapitalisierung *
74,67 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 28.06.2024

Relief Therapeutics SA News

08.02.23 - DGAP
Relief Therapeutics Provides an Update on its Financing Strategy
Relief Therapeutics Holding SA / Key word(s): Financing Relief Therapeutics Provides an Update on its Financing Strategy 08-Feb-2023 / 07:00 CET/CEST Release of an ad hoc ...
17.01.23 - DGAP
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces IRB Approval of Investigator-​Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for ...
27.12.22 - DGAP
Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission
Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form F-1 with the U.S. Securities and ...
27.12.22 - DGAP
Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle Disorders
Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Acer Therapeutics and Relief Therapeutics Announce U.S. FDA Approval of OLPRUVA™ for Patients with Urea Cycle ...
20.12.22 - DGAP
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements
Relief Therapeutics Holding SA / Key word(s): Legal Matter Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Close of Definitive Settlement Agreements 20-...
14.12.22 - DGAP
Relief Therapeutics to Participate in January Investor Meetings
Relief Therapeutics Holding SA / Key word(s): Conference Relief Therapeutics to Participate in January Investor Meetings 14.12.2022 / 07:00 CET/CEST
13.12.22 - DGAP
Relief Therapeutics Announces Issuance of Shares from Authorized Capital
Relief Therapeutics Holding SA / Key word(s): Capital Increase Relief Therapeutics Announces Issuance of Shares from Authorized Capital 13-Dec-2022 / 07:00 CET/CEST Release ...
08.12.22 - DGAP
Relief Therapeutics Announces Executive Leadership Team Changes
Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Announces Executive Leadership Team Changes 08-Dec-2022 / 07:00 CET/CEST Release of an ad ...
05.12.22 - PR Newswire
APR Applied Pharma Research (eine Tochtergesellschaft von Relief Therapeutics) ist unter den Finalisten des Rare Disease International Film Festival 2022
APR Applied Pharma Research (eine Tochtergesellschaft von Relief Therapeutics) ist unter den Finalisten des Rare Disease International Film Festival 2022 PR Newswire
21.11.22 - DGAP
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
Relief Therapeutics Holding SA / Key word(s): Miscellaneous APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease ...
21.11.22 - PR Newswire
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival PR Newswire
21.11.22 - PR Newswire
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival PR Newswire
16.11.22 - DGAP
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and Exchange Commission
Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form F-1 with the U.S. Securities and ...
14.11.22 - DGAP
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement ...
08.11.22 - DGAP
Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. further extend their stay of pending litigation to provide additional time for the parties to finalize their litigation settlement
Relief Therapeutics Holding SA / Key word(s): Legal Matter Relief Therapeutics Holding SA and NRx Pharmaceuticals, inc. further extend their stay of pending litigation to provide ...
07.11.22 - DGAP
Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil)
Relief Therapeutics Holding SA / Key word(s): Research Update Relief Therapeutics Announces Six-Month Stability Data on a New Formulation of RLF-100 (Aviptadil) 07-Nov-2022 / ...
26.10.22 - DGAP
RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. extend their stay of pending litigation to provide additional time for the parties to finalize their settlement
Relief Therapeutics Holding SA / Key word(s): Legal Matter RELIEF THERAPEUTICS Holding SA and NRx Pharmaceuticals, Inc. extend their stay of pending litigation to provide ...
25.10.22 - DGAP
Relief Therapeutics Files Amendment No. 2 to its Form F-6 Registration Statement with the U.S. Securities and Exchange Commission
Relief Therapeutics Holding SA / Key word(s): Miscellaneous Relief Therapeutics Files Amendment No. 2 to its Form F-6 Registration Statement with the U.S. Securities and ...
14.10.22 - DGAP
Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer
Relief Therapeutics Holding SA / Key word(s): Personnel Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer 14-Oct-2022 / 07:00 CET/CEST ...
10.10.22 - DGAP
Relief Announces U.S. Launch of PKU GOLIKE
Relief Therapeutics Holding SA / Key word(s): Market Launch Relief Announces U.S. Launch of PKU GOLIKE 10-Oct-2022 / 07:00 CET/CEST Release of an ad hoc announcement ...

Newssuche

Videos

newspaper
31.10.24 -11,51%
Technical Trading: 83% Trefferquote für diesen Trade
Nasdaq Long Typ: Turbo Open End WKN: VM433C Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »
Anzeige

Aktie im Fokus

1.000 % Chance
Desert Gold Ventures Inc.
0,0465 €
-15,5%
Desert Gold Ventures Inc. Chart
Neuer Gold Rekord bei knapp 2.800 USD und Übernahme-Zirkus!
Mehr zur Aktie »